Just Published: "Global Non-alcoholic Steatohepatitis Market 2016-2020"

NAFL disease, also known as fatty infiltration, is characterized by the accumulation of fat in the liver. It is of two types: NAFL and NASH. Fatty inflammation characterized by higher fat deposition than the normal level, 5%-10%, causes the disease. NASH causes severe inflammation of the liver, leading to damage of the organ. It is a benign condition of unknown etiology and is asymptomatic in nature during its initial stages, resulting in late diagnosis. Conditions such as obesity, diabetes, hyperlipidemia, insulin resistance, and toxicity by drugs such as amiodarone, tamoxifen, and perhexiline maleate can cause NASH.

Technavio's analysts forecast the global NASH market to grow at a CAGR of 24.58% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global NASH market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of off-label drugs, originally indicated for the treatment of diabetes, obesity, and associated conditions.

Full Report Details at
- http://www.fastmr.com/prod/1171607_global_nonalcoholic.aspx?afid=301

The market is divided into the following segments based on geography:

* Americas
* APAC
* EMEA

Technavio's report, Global NASH Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

* Arena Pharmaceuticals
* AstraZeneca
* F Hoffmann-La Roche
* GSK
* Novo Nordisk
* Vivus

Other prominent vendors

* Arisaph Pharmaceuticals
* Cempra Pharmaceuticals
* Galectin Therapeutics
* Galmed Pharmaceuticals
* Genfit
* Gilead
* Immuron
* Interceptpharma
* Raptor Pharmaceutical
* Shire
* Tobira Therapeutics
* Verva
* Viking Therapeutics

Market driver

* Increase in sedentary lifestyle
* For a full, detailed list, view our report

Market challenge

* Limited understanding of disease pathophysiology
* For a full, detailed list, view our report

Market trend

* Patient assistance programs
* For a full, detailed list, view our report

Key questions answered in this report

* What will the market size be in 2020 and what will the growth rate be?
* What are the key market trends?
* What is driving this market?
* What are the challenges to market growth?
* Who are the key vendors in this market space?
* What are the market opportunities and threats faced by the key vendors?
* What are the strengths and weaknesses of the key vendors?

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H2, 2015
- Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2016
- Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2015
- Steatohepatitis Global Clinical Trials Review, H2, 2015
- Global Liver Diseases Therapeutics Market 2015-2019